ScotBio is expanding its R&D programme to explore the potential of cyanobacteria to treat emerging viral pathogens, including coronaviruses. With funding from Medical Research Scotland, a new collaborative partnership with Infection Medicine at the University of Edinburgh will investigate how cyanobacterial extracts, recognized previously for their antiviral activity, can be commercially mass produced using ScotBio’s established production processes and used in the treatment of major emerging viral diseases.
We wish our former Research Scientist, Dr. Keith Bromley, farewell and all the best with his new job. Read about Dr. Bromley’s journey in this brief blog post, describing how we was introduced to ScotBio, the importance of being a hub of academic collaboration, and Dr. Bromley’s outlook on the future of the research he started.
ScotBio
Unit 28
Shairps Business Park
Houstoun Road
Livingston, EH54 5FD
Follow us on social media
